Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Sharp

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
European Urology Oncology|May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate CancerMaría Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Iscience|December 24, 2025
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancerDaniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
European Urology|June 9, 2021
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNASemini Sumanasuriya, George Seed, Harry Parr, et al.
Science Advances|October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancerAntonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
The Journal of Clinical Investigation|June 4, 2024
RNASEH2B loss and PARP inhibition in advanced prostate cancerJuliet Carmichael, Ines Figueiredo, Bora Gurel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
Nature Communications|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stressAndreas Varkaris, Keshan Wang, Mannan Nouri, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
European Urology|September 16, 2022
B7-H3 as a Therapeutic Target in Advanced Prostate CancerChristina Guo, Ines Figueiredo, Bora Gurel, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
European Urology Oncology|May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate CancerMaría Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Iscience|December 24, 2025
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancerDaniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
European Urology|June 9, 2021
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNASemini Sumanasuriya, George Seed, Harry Parr, et al.
Science Advances|October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancerAntonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
The Journal of Clinical Investigation|June 4, 2024
RNASEH2B loss and PARP inhibition in advanced prostate cancerJuliet Carmichael, Ines Figueiredo, Bora Gurel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
Nature Communications|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stressAndreas Varkaris, Keshan Wang, Mannan Nouri, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
European Urology|September 16, 2022
B7-H3 as a Therapeutic Target in Advanced Prostate CancerChristina Guo, Ines Figueiredo, Bora Gurel, et al.
Pageof 12